Anna Karmann, MD PhD

Anna has over 10 years combined experience in industry, clinical practice, and academic research. As an MD, Anna has deep expertise in medical imaging and administered radiopharmaceutical therapies to patients. Prior to RayzeBio, Anna was a consultant at McKinsey & Company where she successfully led projects for pharmaceutical companies, biotech and private equity clients with focus on drug development, R&D portfolio strategy, commercial strategy and operational performance. Anna is a board-certified Radiologist with specialization in Interventional Radiology. She practiced at the Maastricht University Medical Center in the Netherlands and worked at Stanford University as a Physician Scientist. Anna holds a PhD in Biomedical Sciences from the University of Maastricht, Netherlands, as well as an MD from RWTH Aachen University, Germany.